GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Breakout Stocks of Week 12

NASDAQ was up last week (week 11) by 3.09% ending at 13,319.86 points after gaining 399.71 points during the week. Our system has detected some possible breakout stocks for the following week and these should be on your watchlist. These are the stocks that are bouncing up with good increase in volume and are likely to do good in short term. One of these stocks are Navient Corporation NASDAQ:NAVI. This stock has had a buy signal since Dec 30, 2020 when the price was $9.79 and is so far up 35.34% to $13.25. Some other companies are on our watchlist to, among these are Surgery Partners NASDAQ:SGRY FBL Financial Group Inc NYSE:FFG PetMed Express NASDAQ:PETS and CONX Corp. NASDAQ:CONX which all got a breakout pattern emerging.

Date Company Price Week 12
Mar 12, 2021 Navient Corporation $13.25 $13.76 3.85%
Mar 12, 2021 Surgery Partners $42.06 $40.99 -2.54%
Mar 12, 2021 Fbl Financial Group Inc $57.96 $56.68 -2.21%
Mar 12, 2021 Petmed Express $35.76 $34.00 -4.92%
Mar 12, 2021 Conx Corp. $10.10 $10.01 -0.89%

Navient Corporation

NASDAQ:NAVI Strong Buy Candidate Score: 7.84
Strong Buy Candidate Score: 7.84 Mar 12, 2021

Navient CorporationThe Navient Corporation stock price gained 0.684% on the last trading day (Friday, 12th Mar 2021), rising from $13.16 to $13.25. During the last trading day the stock fluctuated 3.83% from a day low at $13.20 to a day high of $13.70. The price has risen in 5 of the last 10 days and is up by 7.03% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 10 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $31.60 million.

On Dec 01, 2022, it was reported that Morgan Stanley gave NAVI a "Equal-Weight" grade with a "upgrade" action.

Navient Corporation holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.

About Navient Corporation:
Navient Corporation provides education loan management and business processing solutions for education, healthcare, and government clients at the federal, state, and local levels in the United States. It operates through three segments: Federal Education Loans, Consumer Lending, and Business Processing. The company owns Federal Family Education Loan Program (FFELP) loans that are insured or guaranteed by state or not-for-profit agencies; and performs servicing and asset recovery services on its own loan portfolio, as well as asset recovery services on FFELP loans owned by other institutions. It also owns, originates, acquires, and services refinance and in-school private education loans; and offers healthcare services that include revenue cycle outsourcing, accounts receivable management, extended business office support, consulting engagement, and public health programs, as well as business processing services to state governments, agencies, court systems, municipalities, and parking and tolling authorities. In addition, the company provides customizable solutions for its clients that include hospitals, hospital systems, medical centers, large physician groups, other healthcare providers, and public health departments; and corporate liquidity portfolio services. Navient Corporation was founded in 1973 and is headquartered in Wilmington, Delaware.

Surgery Partners

NASDAQ:SGRY Strong Buy Candidate Score: 5.09
Strong Buy Candidate Score: 5.09 Mar 12, 2021

Surgery PartnersThe Surgery Partners stock price gained 0.191% on the last trading day (Friday, 12th Mar 2021), rising from $41.98 to $42.06. During the last trading day the stock fluctuated 3.82% from a day low at $40.96 to a day high of $42.53. The price has risen in 7 of the last 10 days and is up by 6.56% over the past 2 weeks. Volume fell on the last day by -269 thousand shares and in total, 265 thousand shares were bought and sold for approximately $11.14 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

On Mar 05, 2024, it was reported that RBC Capital gave SGRY a "Buy" grade with a "hold" action.

Surgery Partners holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.

About Surgery Partners:
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

FBL Financial Group Inc

NYSE:FFG Buy Candidate Score: 4.44
Buy Candidate Score: 4.44 Mar 12, 2021

FBL Financial Group IncThe FBL Financial Group Inc stock price gained 0.0173% on the last trading day (Friday, 12th Mar 2021), rising from $57.95 to $57.96. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 1.43% from a day low at $57.18 to a day high of $58.00. The price has risen in 6 of the last 10 days and is up by 1.61% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 31 thousand more shares were traded than the day before. In total, 69 thousand shares were bought and sold for approximately $4.00 million.

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for FBL Financial Group Inc stock to perform well in the short-term.

About FBL Financial Group Inc:
FBL Financial Group, Inc., through its subsidiaries, sells annuity and individual life insurance products. The Annuity segment sells various traditional annuity products that primarily consist of fixed rate and indexed annuities, and supplementary contracts. The Life Insurance segment offers whole life, term life, and universal life policies. The company markets its products to Farm Bureau members, and other individuals and businesses through exclusive agents and agency managers principally under the consumer brand name of Farm Bureau Financial Services in the Midwestern and Western sections of the United States. The company was founded in 1945 and is headquartered in West Des Moines, Iowa.

PetMed Express

NASDAQ:PETS Buy Candidate Score: 2.45
Buy Candidate Score: 2.45 Mar 12, 2021

PetMedNo changes to the price of PetMed stock on the last trading day (Friday, 12th Mar 2021). During the last trading day the stock fluctuated 2.45% from a day low at $35.17 to a day high of $36.03. The price has risen in 6 of the last 10 days and is up by 3.03% over the past 2 weeks.

On Jul 26, 2022, it was reported that Morgan Stanley gave PETS a "Underweight" grade with a "hold" action.

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for PetMed stock to perform well in the short-term.

About PetMed Express:
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.

CONX Corp.

NASDAQ:CONX Buy Candidate Score: 2.41
Buy Candidate Score: 2.41 Mar 12, 2021

The CONX Corp. stock price gained 0.398% on the last trading day (Friday, 12th Mar 2021), rising from $10.06 to $10.10. During the last trading day the stock fluctuated 1.79% from a day low at $10.01 to a day high of $10.19. The price has fallen in 6 of the last 10 days and is down by -2.32% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 330 thousand more shares were traded than the day before. In total, 733 thousand shares were bought and sold for approximately $7.40 million.

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for CONX Corp. stock to perform well in the short-term period.

About CONX Corp.:
CONX Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or assets. It intends to focus its search on identifying a prospective target operating in the technology, media, and telecommunications industries, including wireless communications industry. CONX Corp. was incorporated in 2020 and is based in Littleton, Colorado.

.

StockInvest.usStock Podcast